TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.690
-0.070 (-3.98%)
At close: Sep 15, 2025, 4:00 PM EDT
1.740
+0.050 (2.96%)
Pre-market: Sep 16, 2025, 8:47 AM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $95.90 million as of September 16, 2025. Its market cap has decreased by -68.18% in one year.
Market Cap
95.90M
Enterprise Value
-25.44M
1-Year Change
-68.18%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $95.90M, a decrease of -73.29%. That is a compound annual growth rate of -27.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 95.90M | -44.17% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |